Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lieberman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Vaccine|September 26, 2006
Preparation and immunogenic properties of a recombinant West Nile subunit vaccineMichael M Lieberman, David E Clements, Steven Ogata, et al.
ACS Infectious Diseases|March 9, 2022
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) VariantAlbert To, Teri Ann S Wong, Michael M Lieberman, et al.
Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|January 26, 2010
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeysDavid E Clements, Beth-Ann G Coller, Michael M Lieberman, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Vaccine|September 26, 2006
Preparation and immunogenic properties of a recombinant West Nile subunit vaccineMichael M Lieberman, David E Clements, Steven Ogata, et al.
ACS Infectious Diseases|March 9, 2022
A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) VariantAlbert To, Teri Ann S Wong, Michael M Lieberman, et al.
Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.
Pageof 3